Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CERo Therapeutics | CERO | Sep 20, 2024 | 0.12 | +36.78 |
Certara | CERT | Sep 20, 2024 | 10.90 | -3.63 |
Cerus | CERS | Sep 20, 2024 | 1.80 | -1.64 |
CervoMed | CRVO | Sep 20, 2024 | 16.84 | -3.61 |
CEVA | CEVA | Sep 20, 2024 | 23.11 | -1.32 |
CF Acquisition VII A | CFFS | Sep 20, 2024 | 11.08 | 0.00 |
CF Bankshares | CFBK | Sep 20, 2024 | 21.56 | -2.58 |
CF Industries | CF | Sep 20, 2024 | 81.61 | -1.83 |
CFSB Bancorp | CFSB | Sep 20, 2024 | 6.72 | +0.98 |
CG Oncology | CGON | Sep 20, 2024 | 39.00 | -0.28 |
CGI | GIB | Sep 20, 2024 | 112.76 | -0.94 |
Chain Bridge I SPAC A | CBRG | Sep 20, 2024 | 11.25 | -0.44 |
Chain Bridge I Units | CBRGU | Sep 20, 2024 | 11.24 | 0.00 |
Champion Homes | SKY | Sep 20, 2024 | 92.81 | -2.97 |
Champions Oncology | CSBR | Sep 20, 2024 | 4.77 | -2.45 |
ChampionX | CHX | Sep 20, 2024 | 30.54 | -0.75 |
Chanson International | CHSN | Sep 20, 2024 | 2.63 | -5.05 |
ChargePoint | CHPT | Sep 20, 2024 | 1.37 | -4.20 |
Charles & Colvard | CTHR | Sep 20, 2024 | 1.77 | -14.08 |
Charles River Laboratories International | CRL | Sep 20, 2024 | 205.79 | -1.83 |
Charles Schwab | SCHW | Sep 20, 2024 | 65.39 | +0.97 |
Chart Industries | GTLS | Sep 20, 2024 | 122.43 | -1.51 |
Chart Industries | GTLS-B | Sep 20, 2024 | 50.26 | -1.47 |
Charter Communications A | CHTR | Sep 20, 2024 | 330.40 | -0.28 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | Sep 20, 2024 | 23.60 | +0.21 |
Chatham Lodging Trust REIT | CLDT | Sep 20, 2024 | 9.02 | -0.66 |
Cheche Group | CCG | Sep 20, 2024 | 0.80 | +0.03 |
Check Point Software Technolgies | CHKP | Sep 20, 2024 | 194.09 | +1.57 |
Check-Cap | CHEK | Sep 20, 2024 | 1.69 | -2.31 |
Checkpoint Therapeutics | CKPT | Sep 20, 2024 | 2.41 | -0.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.